Cited by 3,125Heart Failure Treatment and ManagementElectrolyte and hormonal disordersCardiac Fibrosis and Remodeling

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Cohn, Jay N., Levine, T. Barry, Olivari, Maria Teresa, Garberg, Victoria, Lura, Dennis, Francis, Gary S., Simon, Ada B., Rector, Thomas·1984·New England Journal of Medicine

DOI 10.1056/nejm198409273111303

Open this paper in CoChat — free account

Abstract

Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.

Integrity signals

Registry

Crossref · 10.1056/nejm198409273111303

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citation
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart Failure
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439

Show all 23 references

Research works printed but not linked: 2

Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 601–700 of 1,002

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79
Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction
Kresoja, K.-P., Rommel, K.-P., Fengler, K., von Roeder, M., Besler, C., Lücke, C., Gutberlet, M., Desch, S., Thiele, H., Böhm, M., et al. (2021) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007421 · Cited by 96
Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure
Lataro, R. M., Silva, C. A. A., Fazan, R., Rossi, M. A., Prado, C. M., Godinho, R. O., & Salgado, H. C. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00102.2013 · Cited by 79
Human adult cardiac autonomic innervation: Controversies in anatomical knowledge and relevance for cardiac neuromodulation
Wink, J., van Delft, R., Notenboom, R. G. E., Wouters, P. F., DeRuiter, M. C., Plevier, J. W. M., & Jongbloed, M. R. M. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102674 · Cited by 79
p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload
Yoshida, Y., Shimizu, I., Katsuumi, G., Jiao, S., Suda, M., Hayashi, Y., & Minamino, T. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.06.001 · Cited by 81
β-Blocker Use for the Stages of Heart Failure
Klapholz, M. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.8.718 · Cited by 82
Pathophysiologic and therapeutic implicationsof sleep apnea in congestive heart failure
Bradley, T. D., & Floras, J. S. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80045-5 · Cited by 78
Sleep apnoea and heart failure
Levy, P. A., Naughton, M. T., Tamisier, R., Cowie, M., & Bradley, T. D. (2021) · European Respiratory Journal · doi:10.1183/13993003.01640-2021 · Cited by 82
In search of autonomic balance: the good, the bad, and the ugly
Abboud, F. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00130.2010 · Cited by 80
?2-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts*1
STEINBERG, S. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.018 · Cited by 78
The Valsalva Maneuver: A Bedside “Biomarker” for Heart Failure
Felker, G. M., Cuculich, P. S., & Gheorghiade, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.059 · Cited by 77
Low birth size and final height predict high sympathetic nerve activity in adulthood
Boguszewski, M. C. D. S., Johannsson, G., Fortes, L. C., & Sverrisdóttir, Y. B. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00017 · Cited by 76
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Zannad, F. M., Stough, W. G., Regnault, V., Gheorghiade, M., Deliargyris, E., Gibson, C. M., Agewall, S., Berkowitz, S. D., Burton, P. B. J., Calvo, G., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.018 · Cited by 79
Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction
Vettel, C., Lindner, M., Dewenter, M., Lorenz, K., Schanbacher, C., Riedel, M., Lämmle, S., Meinecke, S., Mason, F. E., Sossalla, S. T., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.310069 · Cited by 78
Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure
Esler, M., & Kaye, D. M. (1998) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(98)00107-6 · Cited by 77
G i -Biased β 2 AR Signaling Links GRK2 Upregulation to Heart Failure
Zhu, W., Petrashevskaya, N. N., Ren, S. V., Zhao, A., Chakir, K., Gao, E., Chuprun, J. K., Wang, Y., Talan, M. I., Dorn, G. W., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.253260 · Cited by 77
Diagnosis and Treatment of Depression in Patients With Congestive Heart Failure
Rustad, J. K., Stern, T. A., Hebert, K. A., & Musselman, D. L. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01511 · Cited by 82
Effect of beta-blockade on heart rate variability in decompensated heart failure
Aronson, D., & Burger, A. J. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00401-6 · Cited by 77
Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects
Notarius, C. F. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1447 · Cited by 77
Evaluation of β-blocker therapy in patients with dilated cardiomyopathy—Clinical meaning of iodine 123–metaiodobenzylguanidine myocardial single-photon emission computed tomography
Yamazaki, J., Muto, H., Kabano, T., Yamashina, S., 南條, 修., & Inoue, A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112783 · Cited by 77
B‐Type Natriuretic Peptide: The Level and the Drug—Partners in the Diagnosis and Management of Congestive Heart Failure
Bhalla, V., Willis, S. L., & Maisel, A. S. (2004) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2004.03310.x · Cited by 77
β 1 -Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure
Cannavò, A., Rengo, G., Liccardo, D., Pagano, G., Zincarelli, C., Angelis, M. C. D., Puglia, R., Pietro, E. D., Rabinowitz, J. E., Barone, M. V., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002659 · Cited by 77
Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis
Adlan, A., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2016) · The Journal of Physiology · doi:10.1113/jp272944 · Cited by 77
Changing mortality in dilated cardiomyopathy
Lenarda, A. D., Secoli, G., Perkan, A., Gregori, D., Lardieri, G., Pinamonti, B., Sinagra, G., Zecchin, M., Camerini, F., & Heart Muscle Disease Study Group (1994) · Heart · doi:10.1136/hrt.72.6_suppl.s46 · Cited by 77
Ability of Heart Rate Variability to Predict Prognosis in Patients With Advanced Congestive Heart Failure
Jiang, W., Hathaway, W. R., McNulty, S. E., Larsen, R. L., Hansley, K. L., Zhang, Y., & O’Connor, C. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00526-2 · Cited by 77
Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients
GROSS, P. A., Pehrisch, H., Rascher, W., Schömig, A., Hackenthal, E., & Ritz, E. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb02391.x · Cited by 77
Congestive Heart Failure in the Elderly
Luchi, R. J., Taffet, G. E., & Teasdale, T. A. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02705.x · Cited by 77
Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease
Paolisso, G., Tagliamonte, M. R., Rizzo, M. R., Gambardella, A., Gualdiero, P., Lama, D., Varricchio, G., Gentile, S., & Varricchio, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00097-1 · Cited by 77
Effects of captopril on survival in patients with heart failure
Newman, T. J., Maskin, C. S., Dennick, L. G., Meyer, J. H., Hallows, B. G., & Cooper, W. H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90221-5 · Cited by 77
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction
Seravalle, G., Quarti‐Trevano, F., Dell’Oro, R., Gronda, E., Spaziani, D., Facchetti, R., Cuspidi, C., Mancia, G., & Grassi, G. M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001856 · Cited by 76
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging
Kioka, H., Yamada, T., Mine, T., Morita, T., Tsukamoto, Y., Tamaki, S., Masuda, M., Okuda, K., Hori, M., & Fukunami, M. (2007) · Heart · doi:10.1136/hrt.2006.094524 · Cited by 76
Sympathetic dysregulation in heart failure: Mechanisms and therapy
Mark, A. Y. L. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181303 · Cited by 75
Usefulness of attenuated heart rate recovery immediately after exercise to predict endothelial dysfunction in patients with suspected coronary artery disease
Huang, P., Leu, H., Chen, J., Cheng, C.-M., Huang, C., Tuan, T., Ding, P. Y., & Lin, S. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.004 · Cited by 76
Proarrhythmic Effects of Intravenous Vasopressors
Tisdale, J. E., Patel, R. V., Webb, C. R., Borzak, S. L., & Zarowitz, B. J. M. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900309 · Cited by 76
Cardiac nitric oxide: Emerging role for nNOS in regulating physiological function
Danson, E., Choate, J., & Paterson, D. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.003 · Cited by 77
Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease
Rockman, H. A., Juneau, C., Chatterjee, K., & Rouleau, J. L. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90579-1 · Cited by 76
Alterations of β-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure
Böhm, M. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2005-4_19 · Cited by 76
Statins and the autonomic nervous system
Millar, P. J., & Floras, J. S. (2013) · Clinical Science · doi:10.1042/cs20130332 · Cited by 75
Recovery of Cardiac Autonomic Responsiveness with Low-Intensity Physical Training in Patients with cHronic Heart Failure
Malfatto, G., Branzi, G., Riva, B., Sala, L., Leonetti, G., & Facchini, M. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00221-5 · Cited by 72
Hypertension as a Risk Factor for Heart Failure
Kannan, A., & Janardhanan, R. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0447-7 · Cited by 75
Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure
Aggarwal, A., Esler, M., Socratous, F., & Kaye, D. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01121-4 · Cited by 75
Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts
Veldkamp, M. W. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2499 · Cited by 75
Differential clinical prognostic classifications in dilated and ischemic adbanced heart failure: The EPICAL study
Alla, F., Briançon, S., Juillière, Y., Mertes, P.-M. E., Villemot, J. P., Zannad, F. M., & The EPICAL Investigators (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90023-1 · Cited by 75
Alterations of ?-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure
B�hm, M. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf00944795 · Cited by 75
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications
Carnevale, D. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00678-w · Cited by 77
Congestive Heart Failure in Copper-Deficient Mice
Elsherif, L., Ortines, R. V., Saari, J. T., & Kang, Y. J. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322807-06 · Cited by 74
Five-minute recording of heart rate variability in severe chronic heart failure: Correlates with right ventricular function and prognostic implications
Lucreziotti, S., Gavazzi, A., Scelsi, L., Inserra, C. A., Klersy, C., Campana, C., Ghio, S., Vanoli, E., & Tavazzi, L. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106168 · Cited by 74
Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure
Kimura, K., Kanazawa, H., Ieda, M., Kawaguchi, H., Miyake, Y., Yagi, T., Arai, T., Sano, M., & Fukuda, K. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.02.005 · Cited by 74
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction
Andrassy, M., Volz, H. C., Riedle, N., Gitsioudis, G., Seidel, C., Laohachewin, D., Zankl, A. R., Kaya, Z., Bierhaus, A., Giannitsis, E., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02369.x · Cited by 72
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration
Kalra, P. R., Sharma, R., Shamim, W., Doehner, W., Wensel, R., Bolger, A. P., Genth‐Zotz, S., Cicoira, M., Coats, A. J. S., & Anker, S. D. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00270-x · Cited by 73
The use of digitalis in heart failure
RAHIMTOOLA, S., & Tak, T. (1996) · Current Problems in Cardiology · doi:10.1016/s0146-2806(96)80001-6 · Cited by 76
The Role of Continuous Positive Airway Pressure in the Treatment of Congestive Heart Failure
Yan, A. T.-K., Bradley, T. D., & Liu, P. P. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1675 · Cited by 72
Inverse Relationship of Subjective Daytime Sleepiness to Sympathetic Activity in Patients With Heart Failure and Obstructive Sleep Apnea
Taranto‐Montemurro, L., Floras, J. S., Millar, P. J., Kasai, T., Gabriel, J. M., Spaak, J., Coelho, F. M. S., & Bradley, T. D. (2012) · CHEST Journal · doi:10.1378/chest.11-2963 · Cited by 78
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
Doehner, W., Rauchhaus, M., Godsland, I. F., Egerer, K., Niebauer, J., Sharma, R., Cicoira, M., Florea, V. G., Coats, A. J. S., & Anker, S. D. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00022-0 · Cited by 73
Do cytokines enable risk stratification to be improved in NYHA functional class III patients?. Comparison with other potential predictors of prognosis
Kell, R. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2780 · Cited by 74
QT Dispersion as a Marker of Risk in Patients Awaiting Heart Transplantation
Pinsky, D. J., Sciacca, E. S. R. R., & Steinberg, J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00072-7 · Cited by 73
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure
Yatsu, T., Tomura, Y., Tahara, A., Wada, K., Kusayama, T., Tsukada, J., Tokioka, T., Uchida, W., Inagaki, O., Iizumi, Y., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00379-9 · Cited by 73
Distinct down-regulation of cardiac ?1- and ?2-adrenoceptors in different human heart diseases
Steinfath, M., Geertz, B., Schmitz, W. L., Scholz, H., Haverich, A., Breil, I., Hanrath, P., Reupcke, C., Sigmund, M., & Lo, H. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168613 · Cited by 73
Suppressing Sympathetic Activation in Congestive Heart Failure
Manolis, A. J., Olympios, C. D., Sifaki, M., Handanis, S. M., Bresnahan, M. R., Gavras, I., & Gavras, H. P. (1995) · Hypertension · doi:10.1161/01.hyp.26.5.719 · Cited by 73
Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart.
Müller, F. U., Boheler, K. R., Thomas Eschenhagen, A., Schmitz, W. L., & Scholz, H. (1993) · Circulation Research · doi:10.1161/01.res.72.3.696 · Cited by 73
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population‐based cohort study*
Forde, K. A., Haynes, K., Troxel, A. B., Trooskin, S. B., Osterman, M. T., Kimmel, S. E., Lewis, J. D., & Re, V. L. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01545.x · Cited by 72
Sympathetic activation in heart failure
Gronda, E., Dusi, V., D’Elia, E., Iacoviello, M., Benvenuto, E., & Vanoli, E. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac030 · Cited by 73
Prediction of Mortality by High-Sensitivity C-Reactive Protein and Brain Natriuretic Peptide in Patients With Dilated Cardiomyopathy
Ishikawa, C., Tsutamoto, T., Fujii, M., Sakai, H., Tanaka, T., & Horie, M. (2006) · Circulation Journal · doi:10.1253/circj.70.857 · Cited by 72
Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart
Kreußer, M. M., Buss, S. J., Krebs, J., Kinscherf, R., Metz, J., Katus, H. A., Haass, M., & Backs, J. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.10.019 · Cited by 72
Autonomic receptor systems in the failing and aging human heart: similarities and differences
Brodde, O., & Leineweber, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.022 · Cited by 72
Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide
McNairy, M., Gardetto, N. J., Clopton, P., Garcia, A., Krishnaswamy, P., Kazanegra, R., Ziegler, M. G., & Maisel, A. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120148 · Cited by 72
The Sympathetic Nervous System and the Renin–Angiotensin–Aldosterone System in Cardiovascular Disease
Cody, R. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00832-1 · Cited by 71
Regulation of the Epstein-Barr Virus C Promoter by AUF1 and the Cyclic AMP/Protein Kinase A Signaling Pathway
Fuentes‐Pananá, E. M., Peng, R., Brewer, G., Tan, J., & Ling, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8166-8175.2000 · Cited by 72
Myofilament dysfunction in cardiac disease from mice to men
Hamdani, N., de Waard, M., Messer, A. E., Boontje, N. M., Kooij, V., van Dijk, S. J., Versteilen, A. M. G., Lamberts, R. R., Merkus, D., dos Remedios, C. G., et al. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-008-9160-y · Cited by 71
Maximum Phosphorylation of the Cardiac Ryanodine Receptor at Serine-2809 by Protein Kinase A Produces Unique Modifications to Channel Gating and Conductance Not Observed at Lower Levels of Phosphorylation
Carter, S., Colyer, J., & Sitsapesan, R. M. (2006) · Circulation Research · doi:10.1161/01.res.0000227506.43292.df · Cited by 71
Beta-blockers in heart failure: Promising or proved?
Doughty, R. N., MacMahon, S. W., & Sharpe, N. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90773-0 · Cited by 69
Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein.
Rockman, H. A., Hamilton, R. A., Jones, L. R., Milano, C. A., Mao, L., & Lefkowitz, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118587 · Cited by 71
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Mettauer, B., Rouleau, J. L., Bichet, D. G., Kortas, C., Manzini, C., Tremblay, G., & Chatterjee, K. (1986) · Circulation · doi:10.1161/01.cir.73.3.492 · Cited by 71
Reversible Sympathetic Overactivity in Hypertensive Patients with Primary Aldosteronism
Kontak, A. C., Wang, Z., Arbique, D., Adams-Huet, B., Auchus, R. J., Nesbitt, S. D., Victor, R. G., & Vongpatanasin, W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0823 · Cited by 71
Short term effect of adaptive servo-ventilation on muscle sympathetic nerve activity in patients with heart failure
Harada, D., Joho, S., Oda, Y., Hirai, T., Asanoi, H., & Inoue, H. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.12.001 · Cited by 70
Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failure
Kiyono, K., Hayano, J., Watanabe, E., Struzik, Z. R., & Yamamoto, Y. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.10.030 · Cited by 72
Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)
Masson, S., Solomon, S. D., Angelici, L., Latini, R., Anand, I. S., PRESCOTT, M. F., Maggioni, A. P., Tognoni, G., & Cohn, J. N. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.06.417 · Cited by 70
Self-citation
Association Between Matrix Metalloproteinase-9 and Worsening Heart Failure Events in Patients with Chronic Heart Failure
Morishita, T., Uzui, H., Mitsuke, Y., Amaya, N., Kaseno, K., Ishida, K., Fukuoka, Y., Ikeda, H., Tama, N., Yamazaki, T., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12137 · Cited by 70
Myocardial calcium signalling and arrhythmia pathogenesis
Scoote, M., & Williams, A. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.034 · Cited by 70
Decreased heart rate recovery after exercise in patients with congestive heart failure: Effect of β-blocker therapy
Racine, N., Blanchet, M., Ducharme, A., Marquis, J., Boucher, J.-M., Juneau, M., & White, M. (2003) · Journal of Cardiac Failure · doi:10.1054/jcaf.2003.47 · Cited by 70
The role of neurohormonal activation in chronic heart failure and postmyocardial infarction
Sigurðsson, A. F., & Swedberg, K. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90558-x · Cited by 70
Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs
Nabofa, W., Alashe, O. O., Oyeyemi, O. T., Attah, A. F., Oyagbemi, A. A., Omóbòwálé, T. O., Adedapo, A. A., & Alada, A. R. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35145-5 · Cited by 69
Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure
Ajijola, O. A., Chatterjee, N. A., Gonzales, M. J., GORNBEIN, J. A., Liu, K., Li, D., Paterson, D. J., Shivkumar, K., Singh, J. P., & Herring, N. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4717 · Cited by 73
Alterations in cAMP‐Mediated Signaling and Their Role in the Pathophysiology of Dilated Cardiomyopathy
Movsesian, M. A., & Bristow, M. R. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)68002-7 · Cited by 69
β-adrenoceptor blocker treatment and the cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure
Brodde, O. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0125-7 · Cited by 69
Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure
Takase, B., Kurita, A., Noritake, M., Uehata, A., Maruyama, T., Nagayoshi, H., Nishioka, T., Mizuno, K., & Nakamura, H. (1992) · Journal of Electrocardiology · doi:10.1016/0022-0736(92)90112-d · Cited by 69
Long-term β-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: A longitudinal heart rate variability study
Lin, J., Chan, H., DU, C., Lin, I.-N., Lai, C.-W., Lin, K.-T., Wu, C., Tseng, Y., & Lien, W.-P. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70219-x · Cited by 69
The Role of Adipose Triglyceride Lipase and Cytosolic Lipolysis in Cardiac Function and Heart Failure
Kintscher, U., Foryst‐Ludwig, A., Haemmerle, G., & Zechner, R. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100001 · Cited by 69
Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load
Nugent, K. L., Chiappelli, J., Rowland, L. M., & Hong, L. E. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.009 · Cited by 69
Ramipril
Frampton, J. E., & Peters, D. H. (1995) · Drugs · doi:10.2165/00003495-199549030-00008 · Cited by 68
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
Dahlström, U., Lindahl, T. L., & Alehagen, U. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0278 · Cited by 68
Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure
Androne, A. S., Hryniewicz, K., Goldsmith, R., Arwady, A., & Katz, S. D. (2003) · Heart · doi:10.1136/heart.89.8.854 · Cited by 67
Sympathetic Neural Burst Amplitude Distribution
Sverrisdóttir, Y. B., Rundqvist, B., Johannsson, G., & Elam, M. (2000) · Circulation · doi:10.1161/01.cir.102.17.2076 · Cited by 64
Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris
Forslund, L., Björkander, I., Ericson, M. O., Held, C., Kahan, T., Rehnqvist, N., & Hjemdahl, P. (2002) · Heart · doi:10.1136/heart.87.5.415 · Cited by 67
The effects of sleep extension on cardiometabolic risk factors: A systematic review
Henst, R. H. P., Pienaar, P. R., Roden, L. C., & Rae, D. E. (2019) · Journal of Sleep Research · doi:10.1111/jsr.12865 · Cited by 68
Prognostic Value of Repeated 123I-Metaiodobenzylguanidine Imaging in Patients With Dilated Cardiomyopathy With Congestive Heart Failure Before and After Optimized Treatments-Comparison With Neurohumoral Factors.
Matsui, T., Tsutamoto, T., Maeda, K., Kusukawa, J., & Kinoshita, M. (2002) · Circulation Journal · doi:10.1253/circj.66.537 · Cited by 68
Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure
Agostoni, P., Marenzi, G., Sganzerla, P., Assanelli, E. M., Guazzi, M., Perego, G. B., Lauri, G., Doria, E., Pepi, M., & Guazzi, M. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80229-x · Cited by 68
An Overview of Regular Dialysis Treatment in Japan as of 31 December 2003
Patient Registration Committee, J. S. F. D. T. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00328.x · Cited by 68
Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets
Qin, F. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00323-6 · Cited by 68
Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction
Pingitore, A., Iervasi, G., Barison, A., Prontera, C., Pratali, L., Emdin, M., Giannessi, D., & Neglia, D. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.05.009 · Cited by 67

Authors: Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1984-09-27
Volume: 311
Issue: 13
Pages: 819-823
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198409273111303
OpenAlex: W2338638760
Cited by: 3,125
References: 23
Citations by year: 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
FWCI: 34.36
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords: plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
MeSH terms: Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks